• Growth and margins: Privi targets 20% revenue growth and expects to maintain its 24% EBITDA margin band in FY27, supported by steady demand for aroma chemicals and 65% back-to-back raw material coverage.
• Long-term financial targets: Management plans to reach ₹5,000 crore in revenue and over ₹1,000 crore in EBITDA within three to four years, funding planned capacity expansions through internal accruals and a maximum borrowing of ₹300–400 crore.
• Subsidiary merger timeline: The merger of Privi Fine Sciences, which is projected to generate ₹130–150 crore in revenue this year, has received BSE and NSE approvals and is expected to conclude via NCLT before the end of the year.
• Promoter stake sale: Promoters divested an 11.23% stake to settle personal debt obligations and increase market liquidity, bringing promoter holding to approximately 60.6%–60.7% with no immediate plans for further sales.